June 2026
The global neuroendocrine tumor treatment market size is estimated to surpass around USD 5.16 billion by 2035 from USD 2.88 billion in 2025, at a solid CAGR of 6.00%.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
July 2025
Explore the pan-tumor oncology treatment market, driven by breakthroughs in immunotherapy, targeted treatments, and the rise of tumor-agnostic drug approvals across multiple cancer types.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The ear nose throat (ENT) treatment market size was estimated to hit around USD 35.15 billion by 2035 increasing from USD 19.96 billion in 2025, with a CAGR of 5.82%.
June 2026
The asthma treatment market size accounted for USD 28.96 billion in 2025 and is expected to hit around USD 36.8 billion by 2035, poised to grow at a CAGR of 2.42%.
June 2026
The US glioblastoma multiforme treatment market size was evaluated at USD 789.54 million in 2025 and is predicted to hit around USD 1,634.84 million by 2035, growing at a CAGR of 7.55%.
June 2026
The global circulating tumor DNA (ctDNA) market size is estimated to hit around USD 30.94 billion by 2035 increasing from USD 7.96 billion in 2025, with a CAGR of 14.54%.
June 2026
The global acne treatment market size was valued at USD 12.37 billion in 2025 and is expected to hit around USD 20.99 billion by 2035, growing at a CAGR of 5.60%.
June 2026
The global renal failure treatment market size is accounted to hit around USD 281.02 billion by 2035 increasing from USD 132.28 billion in 2025, with a CAGR of 7.83%.
June 2026
The global lymphoma treatment market size was evaluated at USD 8.08 billion in 2025 and is predicted to hit around USD 17.81 billion by 2035, growing at a CAGR of 8.22%.
June 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
June 2026
The global oral mucositis treatment market size is estimated to hit around USD 3.96 billion by 2035 increasing from USD 1.99 billion in 2025, with a CAGR of 7.12%.
June 2026
The global respiratory disorders treatment market size is estimated to surpass around USD 218.05 billion by 2035 from USD 121.01 billion in 2025 with a CAGR of 6.07%.
June 2026
The US diabetic foot ulcer treatment market size was evaluated at USD 3.66 billion in 2025 and is predicted to hit around USD 6.58 billion by 2035, growing at a CAGR of 6.04%.
June 2026
The global chronic smell and flavor loss treatment market size is projected to surge around USD 6.70 billion by 2035 from USD 3.65 billion in 2025 with a CAGR of 6.26%.
June 2026
The global rotator cuff injury treatment market size was evaluated at USD 1.39 billion in 2025 and is predicted to hit around USD 2.35 billion by 2035, growing at a CAGR of 5.37%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The U.S. systemic inflammatory response syndrome treatment market size was evaluated at USD 4.88 billion in 2025 and is predicted to hit around USD 8.83 billion by 2035, growing at a CAGR of 6.11%.
June 2026
The global phototherapy treatment market size is estimated to hit around USD 2.68 billion by 2035 increasing from USD 1.77 billion in 2025, with a CAGR of 4.53%.
June 2026
The global knee osteoarthritis injectable treatments market size is estimated to hit around USD 6.78 billion by 2035 from USD 3.46 billion in 2025, with a CAGR of 6.96%.
June 2026
The global circulating tumor cells market size was evaluated at USD 14.68 billion in 2025 and is predicted to hit around USD 54.76 billion by 2035, growing at a CAGR of 14.07%.
June 2026
The U.S. non-invasive aesthetic treatment market size is projected to hit around USD 16.43 billion by 2035, from USD 8.03 billion in 2025, with a notable CAGR of 7.42%.
June 2026
The global liver fibrosis treatment market size is estimated to hit around USD 57.11 billion by 2035 from USD 20.35 billion in 2025, with a solid CAGR of 10.87%.
June 2026
The global mucopolysaccharidosis treatment market size is estimated to surge around USD 11.49 billion by 2035 increasing from USD 4.19 billion in 2025, with a CAGR of 10.61%.
June 2026
The global mouth ulcer treatment market size was calculated at USD 1.68 billion in 2025 and is expected to worth around USD 2.46 billion by 2035 with a CAGR of 3.89%.
June 2026
The global osteoporosis treatment market size is accounted at USD 13.43 billion in 2025 and is projected to hit around USD 21.79 billion by 2035 with a CAGR of 4.96%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
June 2026
The anti-snoring treatment market size was estimated at USD 1.68 billion in 2025 and is expected to surpass around USD 3.65 billion by 2035, with a CAGR of 8.07%.
May 2026
The global postmenopausal osteoporosis treatment market size is calculated at USD 13.48 billion in 2025 and is projected to hit around USD 22.51 billion by 2035 with a CAGR of 5.26%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com